首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
PROCEDE ET DISPOSITIF D'ENREGISTREMENT DES INCIDENTS DE FONCTIONNEMENT DES APPAREILS MEDICAUX
摘要
申请公布号
FR2853980(B1)
申请公布日期
2005.08.26
申请号
FR20030004765
申请日期
2003.04.16
申请人
GEYSER
发明人
OGNIER JEAN FRANCOIS
分类号
A61B1/12;A61M1/10;A61M5/142;A61M13/00;A61M16/00;G07C3/00;G07C3/08;(IPC1-7):G07C11/00
主分类号
A61B1/12
代理机构
代理人
主权项
地址
您可能感兴趣的专利
(A) ;SWITCHER CONTROL SYSTEM
GOLF CLUB
FORMULACIONES FARMACEUTICAS PARA INHALADORES DE POLVO SECO EN LA FORMA DE AGLOMERADOS DUROS
NOVEL TREATED FILLER OR PIGMENT OR MINERAL FOR PAPER, IN PARTICULAR PIGMENT CONTAINING NATURAL CACO3, METHOD FOR MAKING SAME, COMPOSITIONS CONTAINING THEM AND USES
Frigjöring av gelatin og bein-bundete mineraler fra fiskeråstoff for forbedring av fysiske egenskaper og fordöyelighetav fiskeprodukter og fôr
NUTRITIONAL COMPOSITION INTENDED FOR SPECIFIC GASTRO-INTESTINAL MATURATION IN PREMATURE MAMMALS
Adjuvant composition and methods for its use.
Sprøjtestøbefremgangsmåde til såler i ekspanderbare og tværbindende EVA-baserede forbindelser
PROCESS FOR THE PREPARATION OF SIMVASTATIN AND DERIVATIVES THEREOF
SMOKABLE PRODUCT
Fremgangsmåde til at reducere og smelte en forbindelse, som indeholder metal
A PROCESS FOR THE MANUFACTURE OF SOFT TIPPED BLADES
HEATING INSTALLATION AND METHOD FOR OPERATING THE SAME
METHOD FOR LAYING DATA CABLES AND DATA TRANSMISSION DEVICE FOR A COMMUNAL GAS, PRESSURE OR WASTE-WATER PIPE SYSTEM COMPRISING AT LEAST ONE WASTE-WATER DRAIN AND A SERVICE SHAFT
METHOD FOR QUANTITATIVELY AND QUALITATIVELY DETERMINING THE MICROBIAL CONTAMINATION OF SUSPENSIONS, EMULSIONS OR DISPERSIONS CONTAINING MINERALS AND/OR PIGMENTS AND/OR FILLERS AND/OR FIBROUS MATERIALS
WOOD-FIBRE SEMI-FINISHED PRODUCT AND METHOD FOR PRODUCING THE SAME
DIAZABICYCLIC DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
OPERATIONAL PROCESS OF CRAPAUDINE DOOR
HYBRID PROTEIN GENERATION HETERODIMER, DNA MOLECULE, EXPRESS VECTOR, HOST CELL, PRODUCTION METHOD OF HYBRID PROTEIN AND PHARMACEUTICAL MIXTURE
SOLID PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE
